Fig. 2: Samples included in genomic analysis. | Nature Communications

Fig. 2: Samples included in genomic analysis.

From: Tracking the COVID-19 pandemic in Australia using genomics

Fig. 2

Epidemic curve of sequenced patient samples by date of symptom onset, colored by the outcome of sequencing after quality control (QC) procedures applied. Dark blue represents successful sequencing meeting QC parameters; white represents failed sequencing; light blue represents sequences with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reads that did not meet internal QC parameters, but may still yield useful phylogenetic data for analysis.

Back to article page